MedTrace Logo

Antiretroviral Therapy for Acute and Chronic HIV Infection

NCT00796263 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2025-06-04

No results posted yet for this study

Summary

The purpose for this protocol is to provide safe and effective standard ART to SEARCH 010 and SEARCH 013 participants. Participants are enrolled in an acute HIV infection study (SEARCH 010 protocol: 'Establish and characterize an acute HIV infection cohort in a Thai high-risk population') or in a study of chronic HIV infection (SEARCH 013 protocol 'Characteristics of immunity in gut mucosa, spinal fluid, lymph node and blood of HIV negative and HIV positive Thais').

Conditions

  • Acute HIV Infection
  • Chronic HIV Infection

Interventions

DRUG

HAART

1 (lamivudine) or 2 (lamivudine + abacavir) nuceloside/nucleotide analog reverse-transcriptase inhibitor (NRTI) class medications once daily plus dolutegravir(DTG) 50 mg orally once daily

Sponsors & Collaborators

  • ViiV Healthcare

    collaborator INDUSTRY

  • SEARCH Research Foundation

    lead OTHER

Principal Investigators

  • Somchai Sriplienchan, MD, MPH · SEARCH Research Foundation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-13
Primary Completion
2033-06-30
Completion
2033-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00796263 on ClinicalTrials.gov